{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:32:35Z","timestamp":1790728355131,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,11,25]],"date-time":"2012-11-25T00:00:00Z","timestamp":1353801600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s00520-012-1661-y","type":"journal-article","created":{"date-parts":[[2012,11,24]],"date-time":"2012-11-24T00:57:05Z","timestamp":1353718625000},"page":"1287-1293","source":"Crossref","is-referenced-by-count":41,"title":["The impact of medication therapy management in older oncology patients"],"prefix":"10.1007","volume":"21","author":[{"given":"Ting Ting","family":"Yeoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phebe","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lita","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,25]]},"reference":[{"key":"1661_CR1","unstructured":"American Pharmacist Association (APhA). (2004) Medication therapy management services definition and program criteria Jul 2004. Available at http:\/\/www.aacp.org\/resources\/historicaldocuments\/Documents\/MTMServicesDefinitionandProgramCriteria04.pdf . Assessed 05 October 2011"},{"key":"1661_CR2","unstructured":"American College of Clinical Pharmacy Position Statement (2004) Medication therapy management services definition and program criteria. Available at http:\/\/www.accp.com\/docs\/positions\/positionStatements\/pos032_200407.pdf . Assessed 24 October 2011"},{"issue":"3","key":"1661_CR3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.18553\/jmcp.2010.16.3.185","volume":"16","author":"DR Oliveira","year":"2007","unstructured":"Oliveira DR, Brummel AR, Miller DB (2007) Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm 16(3):185\u2013195","journal-title":"J Manag Care Pharm"},{"key":"1661_CR4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1345\/aph.1L524","volume":"43","author":"E Welch","year":"2009","unstructured":"Welch E, Delate T, Chester EA, Stubbings T (2009) Assessment of the impact of medication therapy management delivered to home-based Medicare beneficiaries. Ann Pharmacother 43:603\u2013610","journal-title":"Ann Pharmacother"},{"key":"1661_CR5","unstructured":"http:\/\/www.un.org\/esa\/population\/publications\/worldageing19502050 . Assessed 19 September 2011"},{"issue":"17","key":"1661_CR6","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1200\/JCO.2008.20.8983","volume":"27","author":"BD Smith","year":"2009","unstructured":"Smith BD, Smith GL, Hortobagyi GN, Buchholz TA (2009) Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 27(17):2758\u20132765","journal-title":"J Clin Oncol"},{"key":"1661_CR7","unstructured":"Population Reference Bureau (2010) Today\u2019s research on aging. July. No. 20. http:\/\/www.prb.org\/pdf10\/TodaysResearchAging20.pdf . Assessed 16 September 2011"},{"key":"1661_CR8","unstructured":"http:\/\/www.mcys.gov.sg\/successful_ageing\/Report.html . Accessed 22 November 2009"},{"issue":"4","key":"1661_CR9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.amjopharm.2007.12.002","volume":"5","author":"ER Hajjar","year":"2007","unstructured":"Hajjar ER, Cafiero AC, Hanlon JT (2007) Polypharmacy in elderly patients. Am J Geriatr Pharmacother 5(4):345\u2013351","journal-title":"Am J Geriatr Pharmacother"},{"key":"1661_CR10","doi-asserted-by":"crossref","unstructured":"Terret C (2005) Geriatric oncology\u2014a challenge for the future. Eur Oncol Rev 24\u201326","DOI":"10.17925\/EOH.2005.0.0.24"},{"key":"1661_CR11","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.ejca.2007.06.001","volume":"43","author":"U Wedding","year":"2007","unstructured":"Wedding U, Pientka L, Hoffken K (2007) Quality of life in elderly patients with cancer: a short review. Eur J Cancer 43:2203","journal-title":"Eur J Cancer"},{"key":"1661_CR12","unstructured":"http:\/\/www.moh.gov.sg\/mohcorp\/statistics.aspx?id=5526 . Assessed 22 November 2009"},{"issue":"14","key":"1661_CR13","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1200\/JCO.2007.10.6559","volume":"25","author":"M Extermann","year":"2007","unstructured":"Extermann M, Hurria A (2007) Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol 25(14):1824\u20131831","journal-title":"J Clin Oncol"},{"key":"1661_CR14","first-page":"67","volume":"1","author":"D Poon","year":"2008","unstructured":"Poon D (2008) Challenges in the practice of geriatric oncology in a national comprehensive cancer centre in Asia. Asia-Pac Oncol Haematol 1:67\u201368","journal-title":"Asia-Pac Oncol Haematol"},{"key":"1661_CR15","first-page":"1720","volume":"50","author":"American Society of Hospital Pharmacists","year":"1993","unstructured":"American Society of Hospital Pharmacists (1993) ASHP statement on pharmaceutical care. Am J Hosp Pharm 50:1720\u20131723","journal-title":"Am J Hosp Pharm"},{"issue":"1","key":"1661_CR16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1543-5946(03)80014-4","volume":"1","author":"JT Hanlon","year":"2003","unstructured":"Hanlon JT, Lindblad CIL, Hajjar ER, McCarthy TC (2003) Update on drug-related problems in the elderly. Am J Geriatr Pharmacother 1(1):38\u201343","journal-title":"Am J Geriatr Pharmacother"},{"issue":"25","key":"1661_CR17","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1200\/JCO.2006.06.9039","volume":"24","author":"RM Goldberg","year":"2006","unstructured":"Goldberg RM, Tabah-Fisch I, Bleiberg H et al (2006) Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil\/leucovorin administered bimonthly in elderly cancer patients with colorectal cancer. J Clin Oncol 24(25):4085\u20134091","journal-title":"J Clin Oncol"},{"issue":"12","key":"1661_CR18","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1200\/JCO.2005.03.9289","volume":"24","author":"SM Litchman","year":"2006","unstructured":"Litchman SM, Hollis D, Antonius A et al (2006) Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: cancer and leukemia group B (CALGB 9762). J Clin Oncol 24(12):1846\u20131851","journal-title":"J Clin Oncol"},{"issue":"1","key":"1661_CR19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/107327480701400106","volume":"14","author":"U Wedding","year":"2007","unstructured":"Wedding U, Honecker F, Bokemeyer C, Pientka L, Hoffken K (2007) Tolerance to chemotherapy in elderly patients with cancer. Cancer Control 14(1):44\u201356","journal-title":"Cancer Control"},{"key":"1661_CR20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/ageing\/21.3.202","volume":"21","author":"SM Litchman","year":"1992","unstructured":"Litchman SM, Buchholtz M, Marino J et al (1992) Use of cisplatin for elderly patients. Age Ageing 21:202\u2013204","journal-title":"Age Ageing"},{"key":"1661_CR21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0959-8049(02)00611-1","volume":"39","author":"CH Smorenburg","year":"2003","unstructured":"Smorenburg CH, ten Tije AJ, Bontenbal M et al (2003) Altered clearance of unbound paclitaxel in elderly patients with metastatic breast cancer. Eur J Cancer 39:196\u2013202","journal-title":"Eur J Cancer"},{"issue":"6","key":"1661_CR22","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1200\/JCO.2005.03.082","volume":"23","author":"J Albert","year":"2005","unstructured":"Albert J, Ten T, Verweij J, Carducci MA et al (2005) Prospective evaluation of the pharmacokinetics and toxicity profile of docetaxel in the elderly. J Clin Oncol 23(6):1070\u20131077","journal-title":"J Clin Oncol"},{"issue":"25","key":"1661_CR23","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1200\/JCO.2011.34.7625","volume":"29","author":"A Hurria","year":"2011","unstructured":"Hurria A, Togawa K, Mohile SG et al (2011) Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 29(25):3457\u20133465","journal-title":"J Clin Oncol"},{"key":"1661_CR24","doi-asserted-by":"crossref","first-page":"15s","DOI":"10.1200\/jco.2010.28.15_suppl.9000","volume":"28","author":"M Extermann","year":"2010","unstructured":"Extermann M, Boler I, Reich R et al (2010) The Chemotherapy Risk Assessment Scale for High-age patients (CRASH) score: design and validation. J Clin Oncol 28:15s, suppl; abstract 9000","journal-title":"J Clin Oncol"},{"issue":"3","key":"1661_CR25","first-page":"241","volume":"18","author":"M Rhoads","year":"2003","unstructured":"Rhoads M, Thai A (2003) Physician acceptance rate of pharmacist recommendations to reduce use of potentially inappropriate medications in the assisted living setting. Consult Pharm 18(3):241\u2013247","journal-title":"Consult Pharm"},{"issue":"1","key":"1661_CR26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s11096-007-9155-6","volume":"30","author":"SJ Muenster Von","year":"2008","unstructured":"Von Muenster SJ, Carter BL, Weber CA, Ernst ME, Milchak JL, Steffensmeier JJ, Xu Y (2008) Description of pharmacist interventions during physician\u2013pharmacist co-management of hypertension. Pharm World Sci 30(1):128\u2013135","journal-title":"Pharm World Sci"},{"issue":"7","key":"1661_CR27","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0149-2918(05)00146-3","volume":"27","author":"WR Doucette","year":"2005","unstructured":"Doucette WR, McDonough RP, Klepser D, McCarthy R (2005) Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy. Clin Ther 27(7):1104\u20131111","journal-title":"Clin Ther"},{"issue":"2","key":"1661_CR28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5688\/aj730224","volume":"73","author":"M McCollum","year":"2009","unstructured":"McCollum M, Nuffer W, Ellis SL, Turner CJ (2009) Physician acceptance of pharmacotherapy recommendations made by pharmacy students in a rural pharmacy-based diabetes care and education clinic. Am J Pharm Educ 73(2):24","journal-title":"Am J Pharm Educ"},{"issue":"8","key":"1661_CR29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5688\/aj7308145","volume":"73","author":"LM Lundquist","year":"2009","unstructured":"Lundquist LM, Moye PM (2009) Resident physicians\u2019 acceptance of pharmacy students\u2019 pharmacotherapy recommendations during an ambulatory care advanced pharmacy practice experience. Am J Pharm Educ 73(8):145","journal-title":"Am J Pharm Educ"},{"issue":"5","key":"1661_CR30","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/1049909110391080","volume":"28","author":"S Wilson","year":"2011","unstructured":"Wilson S, Wahler R, Brown J, Doloresco F, Monte SV (2011) Impact of pharmacist intervention on clinical outcomes in the palliative care setting. Am J Hosp Palliat Med 28(5):316\u2013320","journal-title":"Am J Hosp Palliat Med"},{"issue":"3","key":"1661_CR31","first-page":"103","volume":"4","author":"EC Chumney","year":"2006","unstructured":"Chumney EC, Robinson LC (2006) The effects of pharmacist interventions on patients with polypharmacy. Pharm Pract 4(3):103\u2013109","journal-title":"Pharm Pract"},{"key":"1661_CR32","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1345\/aph.1H162","volume":"40","author":"S Shah","year":"2006","unstructured":"Shah S, Dowell J, Greene S et al (2006) Evaluation of clinical pharmacy services in a haematology\/oncology outpatient setting. Ann Pharmacother 40:1527\u20131533","journal-title":"Ann Pharmacother"},{"issue":"5","key":"1661_CR33","first-page":"A4261","volume":"58","author":"LJ Kjeldsen","year":"2011","unstructured":"Kjeldsen LJ, Jensen TB, Jensen JJ et al (2011) Physicians\u2019 evaluation of clinical pharmacy revealed increased focus on quality improvement and cost savings. Dan Med Bull 58(5):A4261","journal-title":"Dan Med Bull"},{"issue":"2","key":"1661_CR34","first-page":"133","volume":"5","author":"NA Alsoud","year":"2010","unstructured":"Alsoud NA, El-Hamamsy M, Zawahry HA, Al-Azizi M (2010) Effects of clinical pharmacist interventions on clinical outcomes in oncology patients. Res J Med Med Sci 5(2):133\u2013141","journal-title":"Res J Med Med Sci"},{"issue":"3","key":"1661_CR35","first-page":"22","volume":"3","author":"MS Ganachari","year":"2010","unstructured":"Ganachari MS, Mahendra Kumar BJ, Shashikala CW, Fibin M (2010) Assessment of drug therapy interventions by clinical pharmacist in a tertiary care hospital. Indian J Pharm Pract 3(3):22\u201328","journal-title":"Indian J Pharm Pract"},{"issue":"4","key":"1661_CR36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2478\/v10019-010-0040-x","volume":"44","author":"L Knez","year":"2010","unstructured":"Knez L, Laaksonen R, Duggan C et al (2010) Evaluation of clinical interventions made by pharmacists in chemotherapy preparation. Radiol Oncol 44(4):249\u2013256","journal-title":"Radiol Oncol"},{"issue":"1","key":"1661_CR37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.18553\/jmcp.2009.15.1.18","volume":"15","author":"MJ Barnett","year":"2009","unstructured":"Barnett MJ, Frank J, Wehring H et al (2009) Analysis of pharmacist provided medication therapy management (MTM) services in community pharmacies over 7\u00a0years. J Manag Care Pharm 15(1):18\u201331","journal-title":"J Manag Care Pharm"},{"issue":"2 Suppl","key":"1661_CR38","first-page":"S18","volume":"14","author":"R McMahan","year":"2008","unstructured":"McMahan R (2008) Operationalizing MTM through the use of health information technology. J Manag Care Pharm 14(2 Suppl):S18\u2013S21","journal-title":"J Manag Care Pharm"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-012-1661-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-012-1661-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-012-1661-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T02:14:33Z","timestamp":1643681673000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-012-1661-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,25]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["1661"],"URL":"https:\/\/doi.org\/10.1007\/s00520-012-1661-y","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,25]]}}}